ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.29
0.71%
US Tech 100
19,519.20
0.44%
S&P 500
5,738.33
0.28%
US Dollar vs CAD
1.34754
-0.06%
Bitcoin
65,239.14
3.34%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ENDRA Life Sciences Inc (NDRA)

  7. ENDRA Life Sciences Inc (NDRA) News

NDRA

ENDRA Life Sciences (NDRA)

ENDRA Life Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NDRA
DateTimeSourceHeadlineSymbolCompany
09/16/20244:28PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NDRAENDRA Life Sciences Inc
09/06/20243:33PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:NDRAENDRA Life Sciences Inc
08/28/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
08/28/20243:17PMBusiness WireENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NDRAENDRA Life Sciences Inc
08/23/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
08/22/20243:14PMBusiness WireENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
08/16/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
08/16/20247:00AMBusiness WireENDRA Life Sciences Announces Reverse Stock SplitNASDAQ:NDRAENDRA Life Sciences Inc
08/15/20244:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NDRAENDRA Life Sciences Inc
08/14/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NDRAENDRA Life Sciences Inc
08/13/20243:05PMBusiness WireENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024NASDAQ:NDRAENDRA Life Sciences Inc
08/13/20248:24AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
08/13/20248:24AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
08/13/20247:00AMBusiness WireENDRA Life Sciences Announces Leadership ChangesNASDAQ:NDRAENDRA Life Sciences Inc
08/09/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
08/07/20247:00AMBusiness WireENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14NASDAQ:NDRAENDRA Life Sciences Inc
07/17/20243:16PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NDRAENDRA Life Sciences Inc
07/17/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
06/14/20243:01PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NDRAENDRA Life Sciences Inc
06/14/20247:00AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NDRAENDRA Life Sciences Inc
06/12/20244:22PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:NDRAENDRA Life Sciences Inc
06/06/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
06/05/20247:20AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NDRAENDRA Life Sciences Inc
06/04/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NDRAENDRA Life Sciences Inc
06/04/20248:21AMBusiness WireENDRA Life Sciences Announces Pricing of $8.0 Million Public OfferingNASDAQ:NDRAENDRA Life Sciences Inc
05/31/20243:21PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NDRAENDRA Life Sciences Inc
05/20/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
05/20/20247:00AMBusiness WireENDRA Provides Update Following In-person Meeting with FDANASDAQ:NDRAENDRA Life Sciences Inc
05/14/20243:26PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NDRAENDRA Life Sciences Inc
05/14/20243:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:NDRA

Your Recent History

LSE
12NF
Municplty 42
CEGG
AIDOCBTC
USOTC
YLDGY
Yanlord Land (PK)
LSE
SOI
Schroder Oriental Income
BIT
P1XO15
NLBNPIT1XO15 20991231 24...
NASDAQ
PABU
iShares Paris Aligned Cl...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved